Pyxis Oncology, Inc.
PYXS
$1.34
$0.021.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.24% | 22.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.29% | 21.79% | |||
| Operating Income | 14.88% | -21.79% | |||
| Income Before Tax | 14.59% | 43.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.25% | 40.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.25% | 40.52% | |||
| EBIT | 14.88% | -21.79% | |||
| EBITDA | 15.18% | -22.45% | |||
| EPS Basic | 14.48% | 40.32% | |||
| Normalized Basic EPS | 15.79% | -26.59% | |||
| EPS Diluted | 14.48% | 40.32% | |||
| Normalized Diluted EPS | 15.79% | -26.59% | |||
| Average Basic Shares Outstanding | 1.42% | -0.32% | |||
| Average Diluted Shares Outstanding | 1.42% | -0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||